Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

NCT01431924 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01431924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01431924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
January 31, 2012
Enrollment
7,779 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma